Showing results (91-100 of 221) with videos related to

Sort By:
Pageof 23
Cancer Cytopathology|September 25, 2023
Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridizationJohn Diks, Zhenya Tang, Mehmet Altan, et al.
Cancer Genetics|December 19, 2024
Microsatellite instability and high tumor mutational burden detected by next generation sequencing are concordant with loss of mismatch repair proteins by immunohistochemistryRichard K Yang, Hector Alvarez, Antony San Lucas, et al.
Oncotarget|March 15, 2018
Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumorsMeenakshi Mehrotra, Rajesh R Singh, Sanam Loghavi, et al.
Journal of Hematology & Oncology|May 9, 2015
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseasesChi Young Ok, Keyur P Patel, Guillermo Garcia-Manero, et al.
Human Pathology|February 11, 2015
Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common originMaria M de la Garza Bravo, Keyur P Patel, Sanam Loghavi, et al.
American Journal of Hematology|August 14, 2013
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrowKhaled Alayed, Keyur P Patel, Sergej Konoplev, et al.
Biology|January 21, 2023
Concurrent Mutations in SF3B1 and PHF6 in Myeloid NeoplasmsZhuang Zuo, L Jeffrey Medeiros, Sofia Garces, et al.
Blood Cancer Journal|August 28, 2020
Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different featuresWen Shuai, Pei Lin, Paolo Strati, et al.
Oncotarget|March 2, 2018
Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencingAndrés E Quesada, Zhihong Hu, Mark J Routbort, et al.
American Journal of Hematology|July 23, 2020
Phase 1 study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patientsGautam Borthakur, Zhihong Zeng, Jorge E Cortes, et al.
Pageof 23